COLLINS HELEN LOUISE

PrivateCIK: 1701247
Location

SOUTH SAN FRANCISCO, CA

COLLINS HELEN LOUISE (CHIEF MEDICAL OFFICER) sold 61.5% of their position (40K shares) of ENLIVEN THERAPEUTICS, INC. on the open market

Open‑market sale worth $1.20M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 2 sales
InsiderCOLLINS HELEN LOUISECIK 1701247
Officer· CHIEF MEDICAL OFFICER
Since Feb 2026
-40K
Net shares
Net seller
$1.20M
Total sold
2
Open market trades
0B · 2S
6
Total transactions
40K acquired · 80K disposed
Non-Derivative Transactions4

Common Stock

Direct
M · Option Exercise

Shares

+29.87K

Price / share

$2.48

Trade value

$74.08K

% of position

119.5%
3/9/2026
25K54.87K

Common Stock

Direct
S · Sale

Shares

29.87K

Price / share

$30.02

Trade value

$896.81K

% of position

54.4%
3/9/2026
54.87K25K

Common Stock

Direct
M · Option Exercise

Shares

+10.13K

Price / share

$2.48

Trade value

$25.12K

% of position

40.5%
3/10/2026
25K35.13K

Common Stock

Direct
S · Sale

Shares

10.13K

Price / share

$30.19

Trade value

$305.83K

% of position

28.8%
3/10/2026
35.13K25K
Total

Net shares

+0.00

Net value

-$1.10M

Derivative Transactions2

Stock Option (right to buy)

Direct
M · Option Exercise
Converts to

Common Stock

29.87K shares

Shares

29.87K

Strike price

2.48

Held after

191.40K

Exercisable

3/9/2026

Stock Option (right to buy)

Direct
M · Option Exercise
Converts to

Common Stock

10.13K shares

Shares

10.13K

Strike price

2.48

Held after

181.27K

Exercisable

3/10/2026
COLLINS HELEN LOUISE — Insider Transaction (Form 4) Filed Mar 11, 2026 | Finecho